Why the study?
The study was conducted to assess the potential of a new unconventional plasma N-Terminal pro BNP assay in detecting cardiac failure and to correlate its levels with heart failure severity and systolic and diastolic dysfunction.
Does plasma N-Terminal pro BNP correlate with the presence and severity of heart failure and ventricular dysfunction?
Does plasma N-Terminal pro BNP correlate with the presence and severity of heart failure and ventricular dysfunction?
Diagnostic study evaluates plasma NT-proBNP levels across severity stages in heart failure, highlighting its utility in identifying systolic and diastolic dysfunction.
Heart failure is a clinical condition in which a deviation in normal cardiac structure or function is accountable for the incapability of the heart to eject or fill with blood at a proportion proportionate to the requirements of the metabolizing tissues. The detection of heart failure is based on clinical symptoms, signs, chest x rays and reaction to the treatment. BNPs are released by the heart ventricles in reaction to volume load or pressure load physiologically and they function to counteract rennin angiotensin system, cause vasodilatation and natriuresis. The BNP evaluation has gained approval already in the recommendations of European Society of Cardiology for the detection of heart failure. We wanted to study the potential of a new unconventional assay plasma N-Terminal pro BNP in detecting cardiac failure, and correlate the levels of plasma N-Terminal pro BNP with the severity of the cardiac failure and levels of plasma N-Terminal Pro BNP with systolic and diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Anjankar et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: